{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:14:50Z","timestamp":1792656890037,"version":"4.5.0"},"publisher-location":"Chichester, UK","reference-count":51,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003376.pub2","type":"reference-entry","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T23:08:27Z","timestamp":1137712107000},"source":"Crossref","is-referenced-by-count":1,"title":["Etidronate for treating and preventing postmenopausal osteoporosis"],"prefix":"10.1002","author":[{"given":"A","family":"Cranney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JD","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Krolicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VA","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BJ","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD003376.pub2-BIB2|cit1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF03343728","article-title":"Prevention of early postmenopausal bone loss with cyclical etidronate","volume":"23","author":"Adami","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"10.1002\/14651858.CD003376.pub2-BIB1|cit2","series-title":"IBMS Second Meeting, San Francisco, California","first-page":"Poster F294","article-title":"Prevention of Early Postmenopausal Bone Loss with Cyclical Etidronate: A Double-Blind, Placebo-Controlled Study","author":"Adami"},{"key":"10.1002\/14651858.CD003376.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01623376","article-title":"The effect of low-dose cyclical etidronate and calcium on bone mass in early postmenopausal women","volume":"3","author":"Evans","year":"1993","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD003376.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s002239900291","article-title":"Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin combinations in Turkish women with postmenopausal osteoporosis: a prospective study","volume":"61","author":"Gurlek","year":"1997","journal-title":"Calci Tissue Int"},{"key":"10.1002\/14651858.CD003376.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0002-9343(97)00019-3","article-title":"The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study","volume":"103","author":"Herd","year":"1997","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003376.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02242451","article-title":"The effect of a modified etidronate cyclical regimen on postmenopausal osteoporosis: A four-year study","volume":"16","author":"GP","year":"1997","journal-title":"Clin Rheum"},{"key":"10.1002\/14651858.CD003376.pub2-BIB7|cit7","first-page":"84","article-title":"Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up)","volume":"82:27","author":"Meunier","year":"1997","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD003376.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF01623461","article-title":"The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: results of three years of treatment","volume":"7","author":"Montessori","year":"1997","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD003376.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/jcem-66-4-747","article-title":"Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study","volume":"66","author":"Pacifici","year":"1988","journal-title":"J Clin Endocrin Metab"},{"key":"10.1002\/14651858.CD003376.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01622291","article-title":"Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapy","volume":"7","author":"Pouilles","year":"1997","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD003376.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","article-title":"Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis","volume":"322","author":"Storm","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003376.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(93)90350-X","article-title":"Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy","volume":"95","author":"Harris","year":"1993","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003376.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003376.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003376.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9343(99)80102-8","article-title":"Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study","volume":"99","author":"Wimalawansa","year":"1995","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003376.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0002-9343(98)00029-1","article-title":"A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination in women with postmenopausal osteoporosis","volume":"104","author":"Wimalawansa","year":"1998","journal-title":"Am J MEd"},{"key":"10.1002\/14651858.CD003376.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02405341","article-title":"Preliminary observations of a form of coherence therapy for osteoporosis","volume":"36","author":"Anderson","year":"1984","journal-title":"Calcif Tissue Int"},{"key":"10.1002\/14651858.CD003376.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(93)90350-X","article-title":"A comparison of the effect of estrogen\/progestogen, high-dose oral calcium, intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy","volume":"95","author":"Hasling","year":"1993","journal-title":"Am J Med"},{"issue":"5","key":"10.1002\/14651858.CD003376.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/cpt1976205593","article-title":"Etidronate disodium in postmenopausal osteoporosis","volume":"20","author":"Heaney","year":"1976","journal-title":"Clin Pharm & Ther"},{"key":"10.1002\/14651858.CD003376.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/BF01738113","article-title":"Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1-38)hPTH and disphosphonate EHDP: Protocol of Study I, Osteoporosis Trial Hannover","volume":"66","author":"Hesch","year":"1988","journal-title":"Klin Wochenschr"},{"key":"10.1002\/14651858.CD003376.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0169-6009(89)90097-4","article-title":"Effects of cyclical therapy for osteoporosis using and an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study","volume":"5","author":"Hodsman","year":"1989","journal-title":"Bone and Mineral"},{"issue":"4","key":"10.1002\/14651858.CD003376.pub2-BIB22|cit22","first-page":"574","article-title":"The treatment of osteoporosis with disodium ethane-1-hydroxy-1,1-diphosphonate","volume":"78","author":"Jowsey","year":"1971","journal-title":"J Lab Clin Med"},{"issue":"2","key":"10.1002\/14651858.CD003376.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jbmr.5650040203","article-title":"Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronate","volume":"4","author":"Mallette","year":"1989","journal-title":"J Bone Miner Res"},{"key":"10.1002\/14651858.CD003376.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/ard.57.6.346","article-title":"Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women","volume":"57","author":"T","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/14651858.CD003376.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0002-9343(97)00278-7","article-title":"Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment","volume":"103","author":"Miller","year":"1997","journal-title":"Am J Med"},{"key":"10.1002\/14651858.CD003376.pub2-BIB26|cit26","article-title":"Comparison of changes in bone mineral in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation","volume":"245-50","author":"Orme","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1002\/14651858.CD003376.pub2-BIB27|cit27","first-page":"968","article-title":"Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis","volume":"78","author":"Ott","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/14651858.CD003376.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF02242942","article-title":"Clnical experience with etidronate in osteoporosis","volume":"13","author":"Ryan","year":"1994","journal-title":"Clin Rheumatol"},{"key":"10.1002\/14651858.CD003376.pub2-BIB29|cit29","article-title":"Effect of etidronate disodium on bone turnover following surgical menopause","volume":"74-9","author":"Smith","year":"1989","journal-title":"Calcif Tissue Int"},{"key":"10.1002\/14651858.CD003376.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/8756-3282(91)90038-K","article-title":"The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: A randomized study comparing intermittent treatment and an ADFR Regime","volume":"12","author":"Steiniche","year":"1991","journal-title":"Bone"},{"key":"10.1002\/14651858.CD003376.pub2-BIB31|cit31","first-page":"1560","article-title":"Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis","volume":"23","author":"Storm","year":"1996","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD003376.pub2-BIB32|cit32","first-page":"1535","article-title":"Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Fracture Intervention Trial Research Group"},{"key":"10.1002\/14651858.CD003376.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01622285","article-title":"Calcitonin versus etidronate for the treatment of postmenopausal osteoporosis: a meta-analysis of published clinical trials","volume":"7","author":"Cardona","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1002\/14651858.CD003376.pub2-BIB34|cit34","first-page":"1113","article-title":"Scientific Advisory Board, Osteoporosis Society of Canada","volume":"155","year":"1996","journal-title":"CMAJ"},{"issue":"6","key":"10.1002\/14651858.CD003376.pub2-BIB35|cit35","first-page":"1222","article-title":"Osteoporosis clinical trials endpoints: candidate variables and clinimetric properties","volume":"24","author":"Cranney","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1002\/14651858.CD003376.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jbmr.5650070413","article-title":"Contribution of vertebral deformities to chronic back pain","volume":"7","author":"Ettinger","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1002\/14651858.CD003376.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/07853899708998743","article-title":"Bisphosphonates: Preclinical aspects and use in osteoporosis","volume":"29","author":"Fleisch","year":"1997","journal-title":"Annals of Medicine"},{"key":"10.1002\/14651858.CD003376.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/096228029300200202","article-title":"Statistical basis of meta-analysis","volume":"2","author":"Fleiss","year":"1993","journal-title":"Stat Methods Med Res"},{"key":"10.1002\/14651858.CD003376.pub2-BIB39|cit39","article-title":"Developing optimal search strategies for detecting clinically sound studies in MEDLINE","volume":"447-58","author":"Haynes","journal-title":"J Am Med Info Ass"},{"key":"10.1002\/14651858.CD003376.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of randomized trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trial"},{"key":"10.1002\/14651858.CD003376.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01623782","article-title":"Guidelines for diagnosis and management of osteoporosis","volume":"7","author":"Kanis","year":"1997","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1002\/14651858.CD003376.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture","volume":"285","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003376.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jbmr.5650100202","article-title":"How many women have osteoporosis now?","volume":"10","author":"Melton","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1002\/14651858.CD003376.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2307\/2528167","article-title":"Small sample considerations in combining 2x2 tables","volume":"23","author":"Naylor","year":"1967","journal-title":"Biometrics"},{"issue":"1","key":"10.1002\/14651858.CD003376.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archinte.160.1.77","article-title":"Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures","volume":"160","author":"Nevitt","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD003376.pub2-BIB46|cit46","first-page":"S262","article-title":"The impact of incident vertebral fractures on health-related quality of life in women with prevalent fractures","volume":"14","author":"Oleksik","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1002\/14651858.CD003376.pub2-BIB47|cit47","article-title":"Coyte PC, Josse RG., and Greenwood CE. Current and projected rates of hip fractures in Canada","volume":"157","author":"Papadimitroupoulos","year":"1997","journal-title":"CMAJ"},{"key":"10.1002\/14651858.CD003376.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0895-4356(94)90004-3","article-title":"Pain and disability associated with new vertebral fractures and other spinal conditions","volume":"47","author":"Ross","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1002\/14651858.CD003376.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003376.pub2-BIB50|cit50","first-page":"S159","article-title":"The impact of incident vertebral fracture of health related quality of life in established postmenopausal osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study","author":"Silverman","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1002\/14651858.CD003376.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s001980170147","article-title":"A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis","volume":"12","author":"Cranney","year":"2001","journal-title":"Osteoporos Int"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003376.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003376.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:19:39Z","timestamp":1628529579000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003376.pub2"}},"subtitle":[],"editor":[{"given":"Ann","family":"Cranney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,1,25]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003376.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD003376.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2006,1,25]]}}}